KPTI is currently covered by 5 analysts with an average price target of $13.67. This is a potential upside of $13.65 (68250%) from yesterday's end of day stock price of $0.02.
Karyopharm Therapeutics's activity chart (see below) currently has 138 price targets and 152 ratings on display. The stock rating distribution of KPTI is 83.33% BUY and 16.67% HOLD.
Analysts' price targets on this stock were met 44.84% of the time, taking 311.96 days on average.
Highest price target for KPTI is $28, Lowest price target is $3, average price target is $13.67.
Most recent stock forecast was given by EDWARD TENTHOFF from PIPER SANDLER on 31-Jul-2026. First documented stock forecast 02-Jun-2015.
Currently out of the existing stock ratings of KPTI, 2 are a HOLD (16.67%), 10 are a BUY (83.33%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 09-Oct-2025
$7
$5.38 (332.10%)
3 months 17 days ago
(31-Jul-2026)
0/3 (0%)
$5.08 (264.58%)
Buy Since 18-Feb-2026
$3
$1.38 (85.19%)
3 months 17 days ago
(31-Jul-2026)
0/3 (0%)
$1.08 (56.25%)
Buy Since 03-Nov-2023
$15
$4.79 (46.91%)
$21
7 months 23 days ago
(25-Mar-2026)
3/5 (60%)
$9.79 (187.91%)
1410
Buy Since 10-Mar-2026
$28
$22.52 (410.95%)
$330
8 months 7 days ago
(10-Mar-2026)
1/2 (50%)
$19.77 (240.22%)
1085
Buy Since 12-Apr-2023
$19
$33
1 years 13 days ago
(04-Nov-2025)
10/19 (52.63%)
$13.35 (236.28%)
277
What is KPTI (Karyopharm Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on KPTI (Karyopharm Therapeutics)?
Which analyst has the most public recommendations on KPTI (Karyopharm Therapeutics)?
Which analyst is the currently most bullish on KPTI (Karyopharm Therapeutics)?
Which analyst is the currently most reserved on KPTI (Karyopharm Therapeutics)?